Autoimmune hepatitis

G Mieli-Vergani, S Heller, P Jara… - Journal of pediatric …, 2009 - journals.lww.com
Autoimmune hepatitis is characterized by inflammatory liver histology, circulating nonorgan-
specific autoantibodies, and increased levels of immunoglobulin G, in the absence of a …

Autoimmune hepatitis in children: what is different from adult AIH?

G Mieli-Vergani, D Vergani - Seminars in liver disease, 2009 - thieme-connect.com
Autoimmune hepatitis (AIH) is characterized by inflammatory liver histology, circulating non-
organ-specific autoantibodies, and increased levels of immunoglobulin (Ig) G in the absence …

EASL Clinical Practice Guidelines: management of cholestatic liver diseases

European Association For The Study Of The Liver - Journal of hepatology, 2009 - Elsevier
EASL Clinical Practice Guidelines (CPG) on the management of cholestatic liver diseases
define the use of diagnostic, therapeutic and preventive modalities, including non-invasive …

[PDF][PDF] High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

KD Lindor, KV Kowdley, VAC Luketic, ME Harrison… - …, 2009 - Wiley Online Library
Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid
(UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients …

[PDF][PDF] A re‐evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

E Alabraba, P Nightingale, B Gunson… - Liver …, 2009 - Wiley Online Library
Previously, we have found that the absence of the colon after liver transplantation (LT)
protects the patient from recurrent primary sclerosing cholangitis (rPSC). As our previous …

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

G Rudolph, D Gotthardt, P Klöters-Plachky… - Journal of …, 2009 - Elsevier
BACKGROUND/AIMS: In primary sclerosing cholangitis (PSC) dominant stenoses are
frequently associated with bacterial, and in part, also fungal infections of the bile ducts. In the …

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

MG Silveira, NJ Torok, AA Gossard… - Official journal of the …, 2009 - journals.lww.com
OBJECTIVES: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of
young adults that is associated with significant morbidity and mortality. No effective medical …

Ursodeoxycholic acid in primary sclerosing cholangitis: meta‐analysis of randomized controlled trials

J Shi, Z Li, X Zeng, Y Lin, WF Xie - Hepatology research, 2009 - Wiley Online Library
Aims: The effect of ursodeoxycholic acid (UDCA) treatment on survival and liver histological
progression of primary sclerosing cholangitis (PSC) remains uncertain. The aim of the …

Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-) transcriptional modulators?

U Beuers, GA Kullak-Ublick, T Pusl, ER Rauws… - Clinical reviews in …, 2009 - Springer
Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic disease of the liver and
bile ducts that is associated with inflammatory bowel disease, generally leads to end-stage …

Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis

SS Glaser, G Alpini - Hepatology, 2009 - journals.lww.com
(PSC), have long suffered from lack of efficacious medical treatments. 1 PSC is a rare
disease that is characterized by chronic inflammation and fibrotic obliteration of the …